AT-527
AT-03A-001
Phase 2 small_molecule terminated
Quick answer
AT-527 for COVID-19 is a Phase 2 program (small_molecule) at Atea Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated